Pitt researchers receive an $18 million renewal from NIAID

The University of Pittsburgh Cancer Institute and Pitt’s schools of medicine and graduate school of public health have received a five-year, $18 million federal grant to continue work on drugs that could provide protection during radiation emergencies, including acts of terrorism and reactor malfunctions.

This is the third time the grant from the National Institute of Allergy and Infectious Diseases has been renewed for Dr. Joel Greenberger, professor and chair of the Department of Radiation Oncology and his research team. It is one of only four awarded by NIAID.